Live feed16:11:36·2017dPRReleaseAMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant PatientsAMAG· AMAG Pharmaceuticals, Inc.Health CareFull content unavailable. See the original source below.Original source
